# US 2018/0023126 A1 · Additive for accelerating hybridization

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0023126 A1
- Document ID: US20180023126A1
- Status: Published application
- Kind: A1
- Application number: 15/549,065
- Filed: 2016-02-03
- Published: 2018-01-25
- Earliest claimed: 2015-02-04
- Assignees: Alma Mater Studiorum - Università di Bologna
- Applicants: Alma Mater Studiorum Universita Di Bologna
- Inventors: Enrico DI OTO; Valentina MONTI; Sofia ASIOLI
- Web page: https://patentgrep.com/patent/US20180023126A1

## CPC

- C12Q 1/6832: Enhancement of hybridisation reaction
- C12Q 1/6841: In situ hybridisation
- C12Q 2527/125: Specific component of sample, medium or buffer
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The present invention describes an additive for accelerating hybridization comprising: a) an aqueous solution of sodium dextran sulphate, b) a salt, c) a buffer system, d) a strong mineral base possibly mixed with at least one polar aprotic solvent, or at least one polar aprotic solvent. The additive described herein enables a reduction in the time required to perform the investigations with molecular probes on histological and cytological samples; the possibility of applying it to the protocol already in use in the routine practices of various laboratories in order to reduce the working time of histological and cytological samples for investigations with molecular probes, with no organisational impacts on the operators' work, enabling a more rapid diagnostic response for the patient and offering the possibility of using the additive described herein without formamide.

## Claims

### Claim 1

An additive for accelerating hybridization comprising
a) an aqueous solution of sodium dextran sulphate,
b) a salt,
c) a buffer system, and
d) a strong mineral base possibly mixed with at least one polar aprotic solvent, or at least one polar aprotic solvent.

### Claim 2 (depends on 1)

The additive of claim 1, wherein said mineral base is a hydroxide of a metal.

### Claim 3 (depends on 2)

The additive of claim 2, wherein said metal hydroxide is selected from the group consisting of sodium hydroxide, lithium hydroxide, potassium hydroxide, rubidium hydroxide, caesium hydroxide, beryllium hydroxide, magnesium hydroxide, calcium hydroxide, strontium hydroxide, barium hydroxide, aluminium hydroxide, gallium hydroxide, indium hydroxide and tin hydroxide.

### Claim 4 (depends on 1)

The additive of claim 1, wherein said polar aprotic solvent is an organic solvent having a dipole moment of at least approximately 2 Debye units, a solubility in water of at least approximately 5% by volume at around room temperature and that does not undergo significant hydrogen exchange at around neutral pH.

### Claim 5 (depends on 4)

The additive of claim 4, wherein said solvent is selected from the group consisting of ethylene carbonate, γ-butyrolactone, tetramethylene sulfone sulphur dioxide, acetonitrile, glycol sulphite/ethylene sulphite, propylene carbonate, ethylene trithiocarbonate, ε-caprolactone, N-methyl pyrrolidinone, acetanilide, N-acetylpyrrolidone, 4-amminopyridine, benzamide, benzimidazole, 1,2,3-benzotriazole, butadiene dioxide, 2,3-butylene carbonate, caprolactone, chloromaleic anhydride, 2-chlorocyclohexanone, chloronitromethane, citraconic anhydride, crotonolactone, cyclopropylnitrile, dimethyl sulphate, dimethyl sulfone, dimethyl sulfoxide, 1,2-dinitrobenzene, 2,4-dinitrotoluene, diphenyl sulfone, ethanesulfonyl chloride, furanic aldehyde, 2-furonitryl, isoxazole, maleic anhydride, malononitrile, 4-methyoxybenzonitrile, 1-methoxy-2-nitrobenzene, 1-methylimidazole, 3-methylisoxazole, N-methylmorpholine-N-oxide, methyl phenyl sulfone, methyl sulfolane, methyl-4-toluene sulfate, 3-nitroaniline, 2-nitrothiophene, 9,10-phenanthrenequinone, phthalic anhydride, 1,3-propane sultone, beta-propiolactone, 2-pyrrolidone, succinonitrile, sulfanilamide, 2,2,6,6-tetrachloro cylcohexanone, thiazole, 3,3,3-trichloropropene, 1,1,2-trichloropropene and 1,2,3-trichloropropene.

### Claim 6 (depends on 1)

The additive of claim 1, wherein said component d) comprises an aprotic polar solvent.

### Claim 7 (depends on 1)

The additive of claim 1, wherein said hybridization is in-situ.

### Claim 8 (depends on 7)

The additive of claim 7, wherein said hybridization is selected from the group consisting of fluorescence hybridization and non-fluorescence hybridization.

### Claim 9 (depends on 1)

The additive of claim 1, for use in determining the genetic constitution of Her2 in breast and gastric cancer in order to assign a targeted therapy.

### Claim 10 (depends on 1)

The additive of claim 1, for use in determining the ALK rearrangement in particular in lung and thyroid cancer in order to assign a targeted therapy.

### Claim 11 (depends on 1)

The additive of claim 1, for use in determining a potential gene and chromosome alteration for diagnostic use.

### Claim 12 (depends on 1)

The additive of claim 1, for use in evaluating 1p36 and 19q13 chromosome deletions as prognostic factors, particularly in glial neoplasms.

### Claim 13 (depends on 1)

The additive of claim 1, for use in the evaluation of the gain of the gene TERC (3q26) as diagnostic/prognostic marker in the potentially malignant lesions of the oral cavity (OPML).

### Claim 14 (depends on 1)

The additive of claim 1, for use in reprocessing samples that underwent hybridization, particularly in situ hybridization.

### Claim 15 (depends on 1)

A method for the hybridization of molecular probes comprising use of the additive of claim 1.

### Claim 16 (depends on 1)

A method for the hybridization of molecular probes characterised in that the additive claim 1 is mixed with the molecular probe.

### Claim 17 (depends on 15)

The method of claim 15, wherein said hybridization is in-situ.

### Claim 18 (depends on 16)

The method of claim 16, wherein said hybridization is selected from the group consisting of FISH, CISH and SISH.

### Claim 19 (depends on 15)

The method of claim 15, wherein deparaffinization is performed hot.
